Issue 11, 2020

Monomer-targeting affinity peptide inhibitors of amyloid with no self-fibrillation and low cytotoxicity

Abstract

We utilized solution-phase biopanning to obtain a de novo peptide (LA12) that specifically bound to the core region of the human amylin monomer. LA12 stabilized the random coil conformation of amylin to suppress aggregation in a dose-dependent manner with the highest suppression effect of 78% and reduced the cytotoxicity of amylin.

Graphical abstract: Monomer-targeting affinity peptide inhibitors of amyloid with no self-fibrillation and low cytotoxicity

Supplementary files

Article information

Article type
Communication
Submitted
06 Nov 2019
Accepted
07 Jan 2020
First published
08 Jan 2020

Chem. Commun., 2020,56, 1633-1636

Monomer-targeting affinity peptide inhibitors of amyloid with no self-fibrillation and low cytotoxicity

Q. Xuan, J. He, M. Li, R. Chai, C. Wang, Y. Wang and P. Wang, Chem. Commun., 2020, 56, 1633 DOI: 10.1039/C9CC08671D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements